Increasing Demand for Non-Surgical & Cost Effective Oncology Treatments to Drive the Global Radiation Therapy Equipment Market
The
global Radiation Therapy Equipment market is projected to reach US$10.6 billion
by 2025, driven by the epidemic spread of cancer across the world, growing
preference for non-surgical cancer treatment options, and increased R&D
focus on the development of sophisticated, cost effective and efficient cancer
treatment equipment.
Cancer has emerged as one of the most critical health
issues confronting the world. As per the World Health Organization (WHO),
cancer is among the leading causes of mortality as well as morbidity across the
world. More than 18 million new cases of cancer are diagnosed each year, with
the risk level higher among the world’s aging population. Changing lifestyles
and dietary habits, physical inactivity, tobacco consumption, and environmental
exposures are contributing to sustained increase in incidence of cancer not
just in developed countries but also in developing economies. With cancer
incidence expected to reach 25 million by 2030, there is increased demand for
minimally invasive and cost efficient therapies. Radiation therapy or
radiotherapy is one technique that has become an integral part of treatment for
cancer patients. By using high-energy radiation from sources such as X-rays,
neutrons, protons, and gamma rays, radiotherapy kills cancer-affected tissues
or prevents multiplication of cancer cells in the body. Increasing preference
for non-surgical techniques is a major factor promoting radiotherapy.
The global market for radiotherapy equipment and software
is expected to post strong growth in the coming years, driven by the rising
incidence of cancer worldwide. Developing countries with growing population and
globalization of unhealthy lifestyles and inadequate healthcare infrastructure
represent underserved markets with immense untapped potential for growth for manufacturers
of radiation therapy equipment. The market is benefiting from the steady pace
of technological advancements and increase in cancer research funding over the
years. Focus will be shed on designing equipment that aid in accurate
diagnosis. Since metastasis, where cancerous cells and tumors spread to organs
resulting in their failure, is the most common cause of cancer-related
mortality, focus is on the development of treatments that can destroy the primary
and secondary tumors known to cause metastasis.
Conventional radiotherapy systems as well as advanced
procedures including Image-Guided
Radiation Therapy (IGRT), Intensity-Modulated Radiation Therapy (IMRT),
stereotactic radiosurgery (SRS), proton therapy and stereotactic body
radiotherapy (SBRT) are gaining widespread acceptance in cancer treatment. The
gradual transition from traditional technologies to highly complex treatment
procedures such as 4D imaging, nanotechnology, intensity-modulated
radiotherapy, particle therapy and stereotactic body radiation therapy is enabling
clinicians to improve accuracy and precision of radiotherapy. Proton therapy is
emerging as a promising treatment technique due to the relatively less risk
associated with the procedure.
As stated by the new market research report on Radiation
Therapy Equipment, the United States represents the largest market
worldwide supported by a favorable multi-payer Oncology Care Model (OCM)
designed to provide high quality coordinated care services and availability of
advanced cancer care delivery system. Asia-Pacific is poised to grow at the
fastest CAGR of 9.6% over the analysis period, driven by rising cases of cancer,
steady increase in healthcare expenditure, and promising growth in medical
tourism.
Major players in the market include Accuray Incorporated,
BrainLab AG, Elekta AB, GE Healthcare, Hitachi America Ltd., IBA Group, Nordion
Inc., Philips Healthcare, RaySearch Laboratories AB, Sumitomo Heavy Industries
Ltd., and Varian Medical Systems Inc., among others.
The research report titled “Radiation
Therapy Equipment – Market Analysis, Trends, and Forecasts” announced by Global Industry Analysts Inc., provides a comprehensive review of market
trends, issues, drivers, mergers, acquisitions and other strategic industry
activities of global companies. The report provides market estimates and
projections for all major geographic markets such as the US, Canada, Japan,
Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe),
Asia-Pacific (China, India and Rest of Asia-Pacific), Middle East & Africa
and Latin America (Brazil and Rest of Latin America). The report analyzes the
Radiation Therapy Equipment market by Therapy Type - External Beam Radiation
Therapy, Internal Radiation Therapy and Systemic Radiation Therapy.
Global Industry
Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.
For
enquiries e-mail us at rsd@strategyr.com or info411@strategyr.com.
For
cutting edge analyst reviews on top industries, follow us on Twitter and connect with us on
Comments
Post a Comment